» Articles » PMID: 180856

Effects of Rhinovirus Infection of Pulmonary Function of Healthy Human Volunteers

Overview
Specialty Pulmonary Medicine
Date 1976 Jul 1
PMID 180856
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The effects of experimentally induced rhinovirus and mycoplasmal respiratory tract infections on the pulmonary function of healthy, young, adult volunteers were investigated prospectively. Before inoculation, 12 volunteers were completely normal, whereas 9 had increased frequency dependence of compliance as their only abnormality of pulmonary function. Rhinovirus infection was induced in 8 of the completely normal volunteers, and 5 developed increased frequency dependence of compliance at the time of illness. These changes returned toward normal during the following 2 weeks and were not associated with concomitant changes in any other parameter of pulmonary function, including "closing volume". Three subjects with increased frequency dependence of compliance as their only abnormality before rhinovirus infection developed no significant change in dynamic compliance or any other abnormality in pulmonary function after infection. No changes in pulmonary function were detected in 3 volunteers with experimentally induced mycoplasmal infection. These finding suggest that although rhinovirus infections are associated primarily with upper respiratory illness, they can produce transient peripheral airway abnormalities in previously normal young adults; however, closing volumes, as well as routine pulmonary function studies, may not detect these changes.

Citing Articles

Effects of Oral Procaterol for Postinfectious Cough in Adults: Single-Centre, Randomized Double-Blind, Placebo-Controlled Trial.

Pornsuriyasak P, Rattanasiri S, Unwanatham N, Kawamatawong T, Jankum P, Thakkinstian A Korean J Fam Med. 2020; 42(2):159-165.

PMID: 32403902 PMC: 8010445. DOI: 10.4082/kjfm.19.0118.


Utility of animal and in vivo experimental infection of humans with rhinoviruses in the development of therapeutic agents for viral exacerbations of asthma and chronic obstructive pulmonary disease.

Del Vecchio A, Branigan P, Barnathan E, Flavin S, Silkoff P, Turner R Pulm Pharmacol Ther. 2014; 30:32-43.

PMID: 25445932 PMC: 7110859. DOI: 10.1016/j.pupt.2014.10.005.


Human rhinoviruses.

Jacobs S, Lamson D, St George K, Walsh T Clin Microbiol Rev. 2013; 26(1):135-62.

PMID: 23297263 PMC: 3553670. DOI: 10.1128/CMR.00077-12.


Effects of viral upper respiratory illness on running gait.

Weidner T, Gehlsen G, Dwyer G, Schurr T J Athl Train. 2006; 32(4):309-14.

PMID: 16558464 PMC: 1320346.


Sport, exercise, and the common cold.

Weidner T, Sevier T J Athl Train. 1996; 31(2):154-9.

PMID: 16558389 PMC: 1318446.